Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
GLP-1 receptor agonists (such as semaglutide and tirzepatide) are FDA-approved for Type 2 diabetes and chronic weight management
On top of that, common gastrointestinal side effects like nausea or vomiting especially when starting GLP-1 therapy can further disrupt how well the contraceptive hormones are absorbed
Beyond Blood Sugar: The Shift in Metabolic Treatment Traditional medications for Type 2 Diabetes (T2D) have historically presented a clinical paradox
In some adults with type 2 diabetes and known heart disease, it may also help reduce the risk of major cardiovascular events
GLP-1 helps to reduce food intake, appetite and hunger and promotes fullness and satiety with the ultimate result of promoting weight loss
Blood sugar changes While semaglutide itself doesn't typically cause dangerous low blood sugar (hypoglycemia), it does lead to more stable blood sugar levels, which can feel different if your body is used to higher blood sugar
